Reaction Details |
| Report a problem with these data |
Target | Tyrosine-protein kinase Lck |
---|
Ligand | BDBM50071665 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_221490 |
---|
IC50 | 600±n/a nM |
---|
Citation | Bullington, JL; Cameron, JC; Davis, JE; Dodd, JH; Harris, CA; Henry, JR; Pellegrino-Gensey, JL; Rupert, KC; Siekierka, JJ The development of novel and selective p56lck tyrosine kinase inhibitors. Bioorg Med Chem Lett8:2489-94 (1999) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Tyrosine-protein kinase Lck |
---|
Name: | Tyrosine-protein kinase Lck |
Synonyms: | 2.7.10.2 | LCK | LCK_HUMAN | LSK | Leukocyte C-terminal Src kinase | Lymphocyte cell-specific protein-tyrosine kinase | Lymphocyte-specific protein tyrosine kinase | P56-LCK | Protein YT16 | Proto-oncogene Lck | Proto-oncogene tyrosine-protein kinase LCK | Src/Lck kinase | T cell-specific protein-tyrosine kinase |
Type: | n/a |
Mol. Mass.: | 57987.83 |
Organism: | Homo sapiens (Human) |
Description: | P06239 |
Residue: | 509 |
Sequence: | MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASP
LQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKAN
SLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKH
YKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQTQKPQKPWWEDEWEV
PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL
VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY
IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK
SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER
PEDRPTFDYLRSVLEDFFTATEGQYQPQP
|
|
|
BDBM50071665 |
---|
n/a |
---|
Name | BDBM50071665 |
Synonyms: | 5-Amino-2-[1-(3,4-dihydroxy-phenyl)-meth-(E)-ylidene]-indan-1,3-dione | CHEMBL81793 |
Type | Small organic molecule |
Emp. Form. | C16H11NO4 |
Mol. Mass. | 281.2628 |
SMILES | Nc1ccc2C(=O)\C(=C/c3ccc(O)c(O)c3)C(=O)c2c1 |
Structure |
|